ArticleAnnals of medicine and surgery (2012)2022

24-Month results of the BRAVO study: A prospective, multi-center study evaluating the clinical outcomes of a ventral hernia cohort treated with OviTex® 1S permanent reinforced tissue matrix.

George DeNoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.